Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Peptic Ulcer

  Free Subscription


Articles published in Am J Gastroenterol

Retrieve available abstracts of 49 articles:
HTML format
Text format



Single Articles


    July 2019
  1. LAI SW
    Proton Pump Inhibitors and Fracture Risk.
    Am J Gastroenterol. 2019 Jul 30. doi: 10.14309/ajg.0000000000000342.
    PubMed     Text format    


    June 2019
  2. NAKAGAWA K, Sawada A, Hoshikawa Y, Nikaki K, et al
    Persistent Postprandial Regurgitation vs Rumination in Patients With Refractory Gastroesophageal Reflux Disease Symptoms: Identification of a Distinct Rumination Pattern Using Ambulatory Impedance-pH Monitoring.
    Am J Gastroenterol. 2019 Jun 26. doi: 10.14309/ajg.0000000000000295.
    PubMed     Text format     Abstract available


    April 2019
  3. BOLTIN D, Levi Z, Gingold-Belfer R, Gabay H, et al
    Impact of Previous Exposure to Macrolide Antibiotics on Helicobacter pylori Infection Treatment Outcomes.
    Am J Gastroenterol. 2019 Apr 25. doi: 10.14309/ajg.0000000000000223.
    PubMed     Text format     Abstract available


  4. YANG J, Zhang Y, Fan L, Zhu YJ, et al
    Correction: Eradication Efficacy of Modified Dual Therapy Compared with Bismuth-Containing Quadruple Therapy as a First-Line Treatment of Helicobacter pylori.
    Am J Gastroenterol. 2019 Apr 3. doi: 10.14309/ajg.0000000000000230.
    PubMed     Text format    


    February 2019
  5. YANG J, Zhang Y, Fan L, Zhu YJ, et al
    Eradication Efficacy of Modified Dual Therapy Compared with Bismuth-Containing Quadruple Therapy as a First-Line Treatment of Helicobacter pylori.
    Am J Gastroenterol. 2019 Feb 25. doi: 10.14309/ajg.0000000000000132.
    PubMed     Text format     Abstract available


    January 2019
  6. KURLANDER JE, Kennedy JK, Rubenstein JH, Richardson CR, et al
    Patients' Perceptions of Proton Pump Inhibitor Risks and Attempts at Discontinuation: A National Survey.
    Am J Gastroenterol. 2019 Jan 23. doi: 10.14309/ajg.0000000000000061.
    PubMed     Text format     Abstract available


  7. SUGIYAMA T
    Proton Pump Inhibitor Use and Fracture Risk: An Update of Drug Safety Communication Needed?
    Am J Gastroenterol. 2019 Jan 18. doi: 10.14309/ajg.0000000000000053.
    PubMed     Text format    


    October 2018
  8. WANG Z, Thrift AP
    Helicobacter pylori Infection and Gastroesophageal Reflux Disease-Barrett's Esophagus-Esophageal Adenocarcinoma Sequence: Reply From Authors.
    Am J Gastroenterol. 2018 Oct 17. pii: 10.1038/s41395-018-0356.
    PubMed     Text format    


    September 2018
  9. KOUNTOURAS J, Doulberis M, Polyzos SA, Zeglinas C, et al
    Helicobacter pylori Infection and Gastroesophageal Reflux Disease-Barrett's Esophagus-Esophageal Adenocarcinoma Sequence.
    Am J Gastroenterol. 2018 Sep 3. pii: 10.1038/s41395-018-0214.
    PubMed     Text format    


    August 2018
  10. CHEN MJ, Chen CC, Chen YN, Chen CC, et al
    Systematic Review with Meta-Analysis: Concomitant Therapy vs. Triple Therapy for the First-Line Treatment of Helicobacter pylori Infection.
    Am J Gastroenterol. 2018 Aug 31. pii: 10.1038/s41395-018-0217.
    PubMed     Text format     Abstract available


    June 2018
  11. KINOSHITA Y, Ishimura N, Ishihara S
    Management of GERD: Are Potassium-Competitive Acid Blockers Superior to Proton Pump Inhibitors?
    Am J Gastroenterol. 2018 Jun 29. pii: 10.1038/s41395-018-0183.
    PubMed     Text format    


  12. QAYED E, Samo S
    The Effect of Hematemesis Type on Outcomes in Upper Gastrointestinal Bleeding.
    Am J Gastroenterol. 2018 Jun 27. pii: 10.1038/s41395-018-0155.
    PubMed     Text format    


  13. TALLEY NJ, Walker MM
    The Rise and Rise of Eosinophilic Gut Diseases Including Eosinophilic Esophagitis Is Probably Not Explained by the Disappearance of Helicobacter pylori, so Who or What's to Blame?
    Am J Gastroenterol. 2018 Jun 18. pii: 10.1038/s41395-018-0125.
    PubMed     Text format     Abstract available


  14. SUDO G, Tanuma T, Nakase H
    Gastric Ulcer Bleeding Due to Left Gastric Artery Pseudoaneurysm.
    Am J Gastroenterol. 2018 Jun 14. pii: 10.1038/s41395-018-0126.
    PubMed     Text format    


  15. CHEY WD, Leontiadis GI, Howden CW, Moss SF, et al
    Correction: ACG Clinical Guideline: Treatment of Helicobacter pylori Infection.
    Am J Gastroenterol. 2018 Jun 12. pii: 10.1038/s41395-018-0132.
    PubMed     Text format     Abstract available


  16. PELLICANO R
    Oral Capsaicin Test and Functional Dyspepsia: Any Consideration for Helicobacter pylori Infection and Concomitant Medications?
    Am J Gastroenterol. 2018 Jun 11. pii: 10.1038/s41395-018-0153.
    PubMed     Text format    


  17. WANG Z, Shaheen NJ, Whiteman DC, Anderson LA, et al
    Helicobacter pylori Infection Is Associated With Reduced Risk of Barrett's Esophagus: An Analysis of the Barrett's and Esophageal Adenocarcinoma Consortium.
    Am J Gastroenterol. 2018 Jun 8. pii: 10.1038/s41395-018-0070.
    PubMed     Text format     Abstract available


  18. BAJAJ JS, Acharya C, Fagan A, White MB, et al
    Proton Pump Inhibitor Initiation and Withdrawal affects Gut Microbiota and Readmission Risk in Cirrhosis.
    Am J Gastroenterol. 2018 Jun 6. pii: 10.1038/s41395-018-0085.
    PubMed     Text format     Abstract available


  19. ALEXEEVA O, Keswani RN, Pandolfino JE, Liebovitz D, et al
    Electronic Clinical Decision Support Tools for Obesity and Gastroesophageal Reflux Disease: The Provider's Perspective.
    Am J Gastroenterol. 2018 Jun 1. pii: 10.1038/s41395-018-0092.
    PubMed     Text format    


    April 2018
  20. YADLAPATI R, Vaezi MF, Vela MF, Spechler SJ, et al
    Management options for patients with GERD and persistent symptoms on proton pump inhibitors: recommendations from an expert panel.
    Am J Gastroenterol. 2018 Apr 24. pii: 10.1038/s41395-018-0045.
    PubMed     Text format     Abstract available


    March 2018
  21. MOLINA-INFANTE J, Gutierrez-Junquera C, Savarino E, Penagini R, et al
    Helicobacter pylori infection does not protect against eosinophilic esophagitis: results from a large multicenter case-control study.
    Am J Gastroenterol. 2018 Mar 15. pii: 10.1038/s41395-018-0035.
    PubMed     Text format     Abstract available


  22. CHAHAL P
    Continuing Medical Education Questions: March 2018: Severity And Outcomes Of Upper Gastrointestinal Bleeding With Bloody Vs. Coffee-Grounds Hematemesis.
    Am J Gastroenterol. 2018;113:367.
    PubMed     Text format    


    February 2018
  23. GLASINOVIC E, Wynter E, Arguero J, Ooi J, et al
    Treatment of supragastric belching with cognitive behavioral therapy improves quality of life and reduces acid gastroesophageal reflux.
    Am J Gastroenterol. 2018 Feb 20. pii: ajg201815. doi: 10.1038/ajg.2018.
    PubMed     Text format     Abstract available


    January 2018
  24. LAINE L, Laursen SB, Zakko L, Dalton HR, et al
    Severity and Outcomes of Upper Gastrointestinal Bleeding With Bloody Vs. Coffee-Grounds Hematemesis.
    Am J Gastroenterol. 2018 Jan 30. pii: ajg20185. doi: 10.1038/ajg.2018.
    PubMed     Text format     Abstract available


  25. HSU PI, Tsai FW, Kao SS, Kao JY, et al
    Time to Make a Change in the Cutoff Value of Clarithromycin Resistance in the Treatment of Helicobacter pylori Infection.
    Am J Gastroenterol. 2018;113:142-143.
    PubMed     Text format    


    December 2017
  26. MOAYYEDI P, Lewis MA
    Proton Pump Inhibitors and Dementia: Deciphering the Data.
    Am J Gastroenterol. 2017;112:1809-1811.
    PubMed     Text format     Abstract available


  27. ZULLO A, De Francesco V, Vaira D
    Is Double-Dose Esomeprazole With Bismuth Really Safe?
    Am J Gastroenterol. 2017;112:1894-1895.
    PubMed     Text format    


    October 2017
  28. MOLINA-INFANTE J, Lucendo AJ
    Proton Pump Inhibitor Therapy for Eosinophilic Esophagitis: A Paradigm Shift.
    Am J Gastroenterol. 2017 Oct 31. doi: 10.1038/ajg.2017.
    PubMed     Text format    


  29. YADLAPATI R, Pandolfino JE, Alexeeva O, Gregory DL, et al
    The Reflux Improvement and Monitoring (TRIM) Program Is Associated With Symptom Improvement and Weight Reduction for Patients With Obesity and Gastroesophageal Reflux Disease.
    Am J Gastroenterol. 2017 Oct 10. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


  30. DAI C, Cao Q, Jiang M
    Proton-Pump Inhibitor Use and the Risk of First-Time Ischemic Stroke in the General Population.
    Am J Gastroenterol. 2017;112:1620-1621.
    PubMed     Text format    


    July 2017
  31. HSU PI, Tsai FW, Kao SS, Hsu WH, et al
    Ten-Day Quadruple Therapy Comprising Proton Pump Inhibitor, Bismuth, Tetracycline, and Levofloxacin is More Effective than Standard Levofloxacin Triple Therapy in the Second-Line Treatment of Helicobacter pylori Infection: A Randomized Controlled Tria
    Am J Gastroenterol. 2017 Jul 18. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


  32. TAIPALE H, Tolppanen AM, Tiihonen M, Tanskanen A, et al
    No Association Between Proton Pump Inhibitor Use and Risk of Alzheimer's Disease.
    Am J Gastroenterol. 2017 Jul 11. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


  33. GEORGOPOULOS SD, Xirouchakis E
    Which Regimens Should Be Used and Which Rejected for the Treatment of Helicobacter pylori?
    Am J Gastroenterol. 2017;112:1168-1169.
    PubMed     Text format    


    May 2017
  34. AGREUS L, Svardsudd K, Talley NJ, Jones MP, et al
    Corrigendum: Natural History of Gastroesophageal Reflux Disease and Functional Abdominal Disorders: A Population-Based Study.
    Am J Gastroenterol. 2017 May 23. doi: 10.1038/ajg.2017.
    PubMed     Text format    


  35. GOYAL H, Katner H
    Proton Pump Inhibitors and Clostridium difficile Infection.
    Am J Gastroenterol. 2017;112:805.
    PubMed     Text format    


    April 2017
  36. WANG YF, Chen YT, Luo JC, Chen TJ, et al
    Proton-Pump Inhibitor Use and the Risk of First-Time Ischemic Stroke in the General Population: A Nationwide Population-Based Study.
    Am J Gastroenterol. 2017 Apr 11. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


  37. UEHARA A, Okumura T
    Esophageal Anisakiasis Mimicking Gastroesophageal Reflux Disease.
    Am J Gastroenterol. 2017;112:532.
    PubMed     Text format    


  38. SUGIYAMA T, Oda H
    Proton Pump Inhibitors and Hip Strength.
    Am J Gastroenterol. 2017;112:651-652.
    PubMed     Text format    


  39. ZHU T, Yuan LQ
    Complex Relationship Between Proton Pump Inhibitor Use and Bone Health.
    Am J Gastroenterol. 2017;112:651.
    PubMed     Text format    


    March 2017
  40. ZIRK-SADOWSKI J, Masoli JA, Strain WD, Delgado J, et al
    Proton-Pump Inhibitors and Fragility Fractures in Vulnerable Older Patients.
    Am J Gastroenterol. 2017;112:520-523.
    PubMed     Text format    


    February 2017
  41. XING X, Cui Y, Wang J, Wang J, et al
    Endoscopic Hemostasis for a Massively Bleeding Large Gastric Ulcer with Deep Base.
    Am J Gastroenterol. 2017;112:210.
    PubMed     Text format    


    January 2017
  42. JENSEN DM, Eklund S, Persson T, Ahlbom H, et al
    Reassessment of Rebleeding Risk of Forrest IB (Oozing) Peptic Ulcer Bleeding in a Large International Randomized Trial.
    Am J Gastroenterol. 2017 Jan 17. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


  43. CHEY WD, Leontiadis GI, Howden CW, Moss SF, et al
    ACG Clinical Guideline: Treatment of Helicobacter pylori Infection.
    Am J Gastroenterol. 2017 Jan 10. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


  44. VAEZI MF, Choksi Y
    Mucosal Impedance: A New Way To Diagnose Reflux Disease and How It Could Change Your Practice.
    Am J Gastroenterol. 2017;112:4-7.
    PubMed     Text format    


    December 2016
  45. HSU PI, Wu DC, Tsay FW, Cheng JS, et al
    Histamine-2 Receptor Antagonist Cannot Prevent Recurrent Peptic Ulcers in Patients With Atherosclerotic Diseases Who Receive Platelet ADP Receptor Antagonist Monotherapy: A Randomized-Controlled, Double-Blind, and Double-Dummy Trial.
    Am J Gastroenterol. 2016 Dec 6. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


    November 2016
  46. TARGOWNIK LE, Goertzen AL, Luo Y, Leslie WD, et al
    Long-Term Proton Pump Inhibitor Use Is Not Associated With Changes in Bone Strength and Structure.
    Am J Gastroenterol. 2016 Nov 15. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


    October 2016
  47. PETERSON K, Bjorkman DJ
    Editorial: Intravenous Proton Pump Inhibitors for Bleeding Peptic Ulcer: What is the Most Cost-Effective Approach?
    Am J Gastroenterol. 2016;111:1399-1401.
    PubMed     Text format     Abstract available


    September 2016
  48. CHEN Q, Zhang W, Fu Q, Liang X, et al
    Rescue Therapy for Helicobacter pylori Eradication: A Randomized Non-Inferiority Trial of Amoxicillin or Tetracycline in Bismuth Quadruple Therapy.
    Am J Gastroenterol. 2016 Sep 27. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


    July 2016
  49. ZHANG H, Wang Z, Cao D
    False Aneurysm of the Common Hepatic Artery Ruptured Into the Duodenum.
    Am J Gastroenterol. 2016;111:922.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Peptic Ulcer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: